Galderma Initiates Two New Clinical Trials Investigating Nemolizumab in Patients With Systemic Sclerosis and Chronic Pruritus of Unknown Origin

2025年06月27日 14:13:10

打印 放大 缩小

Systemic Sclerosis (SSc) is a life-threatening autoimmune disease that causes severe inflammation and fibrosis, while Chronic Pruritus of Unknown Origin (CPUO) is characterized by a persistent, chronic itch with an unknown cause1-3
Nemolizumab is the first approved monoclonal antibody that specifically targets the IL-31 receptor alpha, inhibiting the signaling of IL-31. It is approved for the treatment of moderate-to-severe atopic dermatitis and prurigo nodularis by multiple regulatory authorities around the world4-6
IL-31 is a neuroimmune cytokine that is involved in inflammation and fibrosis – both hallmarks of SSc – and drives itch, a key symptom of CPUO1,3,4
Enrollment for Galderma’s phase II studies of nemolizumab is planned to begin in H2 2025

ZUG, Switzerland--(BUSINESS WIRE)--Galderma (SIX: GALD), the pure-play dermatology category leader, today announced the initiation of two new clinical trials to investigate the efficacy and safety of nemolizumab in treating patients living with Systemic Sclerosis (SSc) and Chronic Pruritus of Unknown Origin (CPUO) – two chronic conditions with high unmet need.1-3,7

Nemolizumab is a monoclonal antibody that specifically targets the IL-31 receptor alpha, inhibiting the signaling of IL-31, a neuroimmune cytokine that plays a role in driving itch – the main symptom of CPUO – and inflammation and fibrosis, which are hallmarks of SSc.1,3,4

 

“Investigating nemolizumab in two new trials in Systemic Sclerosis and Chronic Pruritus of Unknown Origin, both of which are associated with poor patient outcomes and low quality of life, underscores our commitment to addressing skin conditions with high unmet needs. These trials may help us better understand these complex diseases and offer hope for patients seeking relief from these severe and potentially life-threatening conditions.”

BALDO SCASSELLATI SFORZOLINI, M.D., PH.D.

GLOBAL HEAD OF R&D

GALDERMA

 

 

责任编辑:admin

相关阅读

天猫网友:离岛║Bombastic Love
评论:真正的爱情,不是一见钟情,而是日久生情 人人都说我很听话,其实我只听自己的话。

猫扑网友:听ヽ天甾哭泣
评论:我妈就生了这么一个限量版的我,你看着办吧Q_Q

百度网友:你就如此不堪
评论:婚外情可以是个浪漫的故事,但离婚则是一次惨痛的事故。

网易网友:遗忘。Forgotten.
评论:你复杂的五官,掩饰不了你朴素的智商。

其它网友:以死换温柔◇
评论:我谈过最长的恋爱,就是自恋

凤凰网友:黒色曼陀罗
评论:这么不要脸,这么没心没肺,你的体重应该会很轻吧

腾讯网友:▲戏子  2/5,°
评论:连贝克汉姆都不知道,你丫还有什么资格敢跟我谈篮球

淘宝网友:大把大把的钱
评论:人生就是这样:不是你混日子;就是日子把自己混了

搜狐网友:▲ 难分 2amor〃
评论:每当我找到了成功的钥匙,就有人把锁给换了。

本网网友:失魂人*pugss
评论:好名声是女人最体面的嫁妆。